Login to Your Account

'X-Chem' marks the spot for Bayer in sweetened drug discovery deal

By Marie Powers
News Editor

Tuesday, July 12, 2016

Bayer AG and privately held X-Chem Inc. expanded their global drug discovery collaboration, initiated in 2012, to encompass the entire bandwidth of therapeutic areas and target classes from Bayer's R&D pipeline.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription